Seres Therapeutics Inc
F:1S9

Watchlist Manager
Seres Therapeutics Inc Logo
Seres Therapeutics Inc
F:1S9
Watchlist
Price: 0.2 EUR Market Closed
Market Cap: 30.3m EUR

Intrinsic Value

The intrinsic value of one 1S9 stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.2 EUR, Seres Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

1S9 Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Seres Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

1S9 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 1S9 usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about 1S9?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 1S9 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Seres Therapeutics Inc.

Explain Valuation
Compare 1S9 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MCRB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Seres Therapeutics Inc

Current Assets 51.5m
Cash & Short-Term Investments 47.6m
Receivables 777k
Other Current Assets 3.1m
Non-Current Assets 91.9m
PP&E 83.2m
Other Non-Current Assets 8.7m
Current Liabilities 22.4m
Accounts Payable 1.7m
Accrued Liabilities 18.8m
Other Current Liabilities 1.9m
Non-Current Liabilities 77.3m
Other Non-Current Liabilities 77.3m
Efficiency

Free Cash Flow Analysis
Seres Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Seres Therapeutics Inc

Revenue
351k USD
Operating Expenses
-103.8m USD
Operating Income
-103.4m USD
Other Expenses
108.8m USD
Net Income
5.4m USD
Fundamental Scores

1S9 Profitability Score
Profitability Due Diligence

Seres Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Seres Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

1S9 Solvency Score
Solvency Due Diligence

Seres Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Seres Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1S9 Price Targets Summary
Seres Therapeutics Inc

Wall Street analysts forecast 1S9 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1S9 is 0.29 EUR with a low forecast of 0.28 EUR and a high forecast of 0.32 EUR.

Lowest
Price Target
0.28 EUR
38% Upside
Average
Price Target
0.29 EUR
46% Upside
Highest
Price Target
0.32 EUR
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Seres Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MCRB is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MCRB Insider Trading
Buy and sell transactions by insiders

1S9 News

What is the Intrinsic Value of one 1S9 stock?

The intrinsic value of one 1S9 stock under the Base Case scenario is hidden EUR.

Is 1S9 stock undervalued or overvalued?

Compared to the current market price of 0.2 EUR, Seres Therapeutics Inc is hidden .

Back to Top